The rise and fall of triple nucleoside reverse transcriptase inhibitor (NRTI) regimens.
Title: | The rise and fall of triple nucleoside reverse transcriptase inhibitor (NRTI) regimens. |
---|---|
Authors: | Jose R. Arribas |
Source: | Journal of Antimicrobial Chemotherapy (JAC); Sep2004, Vol. 54 Issue 3, p587-592, 6p |
Abstract: | Triple nucleoside reverse transcriptase inhibitor (NRTI) regimens have attracted much interest due to their potential to (1) simplify dosing, with potential gains in adherence to treatment, and (2) reduce or even reverse dyslipidaemia associated with protease inhibitor (PI) therapy. A variety of triple NRTI combinations have been investigated, in both antiretroviral-naive and antiretroviral-experienced HIV-infected patients. Many of these trials have generated disappointing results, and some have been prematurely discontinued due to poor efficacy. This article reviews the background to the development of triple NRTI regimens, and the mounting evidence that this approach is suboptimal for antiretroviral-naive patients. Indeed, some triple NRTI regimens should never be used in this population. A role for triple NRTI combinations as a simplification strategy in treatment-experienced patients whose HIV is well controlled has been suggested, but emerging evidence indicates that such an approach can, under adequate selection pressure, lead to the emergence of mutations and viral load rebound. This commentary discusses the factors that appear to influence patients' responses to triple NRTI therapy, and their implications for patient selection. [ABSTRACT FROM AUTHOR] |
Copyright of Journal of Antimicrobial Chemotherapy (JAC) is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
Database: | Complementary Index |
FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edb&genre=article&issn=03057453&ISBN=&volume=54&issue=3&date=20040901&spage=587&pages=587-592&title=Journal of Antimicrobial Chemotherapy (JAC)&atitle=The%20rise%20and%20fall%20of%20triple%20nucleoside%20reverse%20transcriptase%20inhibitor%20%28NRTI%29%20regimens.&aulast=Jose%20R.%20%20Arribas&id=DOI:10.1093/jac/dkh384 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
---|---|
Header | DbId: edb DbLabel: Complementary Index An: 20161211 RelevancyScore: 832 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 832.067504882813 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: The rise and fall of triple nucleoside reverse transcriptase inhibitor (NRTI) regimens. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Jose+R%2E++Arribas%22">Jose R. Arribas</searchLink> – Name: TitleSource Label: Source Group: Src Data: Journal of Antimicrobial Chemotherapy (JAC); Sep2004, Vol. 54 Issue 3, p587-592, 6p – Name: Abstract Label: Abstract Group: Ab Data: Triple nucleoside reverse transcriptase inhibitor (NRTI) regimens have attracted much interest due to their potential to (1) simplify dosing, with potential gains in adherence to treatment, and (2) reduce or even reverse dyslipidaemia associated with protease inhibitor (PI) therapy. A variety of triple NRTI combinations have been investigated, in both antiretroviral-naive and antiretroviral-experienced HIV-infected patients. Many of these trials have generated disappointing results, and some have been prematurely discontinued due to poor efficacy. This article reviews the background to the development of triple NRTI regimens, and the mounting evidence that this approach is suboptimal for antiretroviral-naive patients. Indeed, some triple NRTI regimens should never be used in this population. A role for triple NRTI combinations as a simplification strategy in treatment-experienced patients whose HIV is well controlled has been suggested, but emerging evidence indicates that such an approach can, under adequate selection pressure, lead to the emergence of mutations and viral load rebound. This commentary discusses the factors that appear to influence patients' responses to triple NRTI therapy, and their implications for patient selection. [ABSTRACT FROM AUTHOR] – Name: Abstract Label: Group: Ab Data: <i>Copyright of Journal of Antimicrobial Chemotherapy (JAC) is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=20161211 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/jac/dkh384 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 587 Titles: – TitleFull: The rise and fall of triple nucleoside reverse transcriptase inhibitor (NRTI) regimens. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jose R. Arribas IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: Sep2004 Type: published Y: 2004 Identifiers: – Type: issn-print Value: 03057453 Numbering: – Type: volume Value: 54 – Type: issue Value: 3 Titles: – TitleFull: Journal of Antimicrobial Chemotherapy (JAC) Type: main |
ResultId | 1 |